- Home
- CLPT vs DCTH Comparison
CLPT vs DCTH Comparison
Compare CLPT & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- DCTH
- Stock Information
- Founded
- CLPT 1998
- DCTH 1988
- Country
- CLPT United States
- DCTH United States
- Employees
- CLPT N/A
- DCTH N/A
- Industry
- CLPT Medical/Dental Instruments
- DCTH Medical/Dental Instruments
- Sector
- CLPT Health Care
- DCTH Health Care
- Exchange
- CLPT Nasdaq
- DCTH Nasdaq
- Market Cap
- CLPT 355.7M
- DCTH 305.2M
- IPO Year
- CLPT N/A
- DCTH N/A
- Fundamental
- Price
- CLPT $11.84
- DCTH $9.76
- Analyst Decision
- CLPT Strong Buy
- DCTH Strong Buy
- Analyst Count
- CLPT 2
- DCTH 4
- Target Price
- CLPT $12.00
- DCTH $21.50
- AVG Volume (30 Days)
- CLPT 248.3K
- DCTH 459.4K
- Earning Date
- CLPT 11-07-2024
- DCTH 11-08-2024
- Dividend Yield
- CLPT N/A
- DCTH N/A
- EPS Growth
- CLPT N/A
- DCTH N/A
- EPS
- CLPT N/A
- DCTH N/A
- Revenue
- CLPT $30,429,000.00
- DCTH $22,644,000.00
- Revenue This Year
- CLPT $34.39
- DCTH $1,562.76
- Revenue Next Year
- CLPT $19.93
- DCTH $117.72
- P/E Ratio
- CLPT N/A
- DCTH N/A
- Revenue Growth
- CLPT 36.34
- DCTH 945.91
- 52 Week Low
- CLPT $5.11
- DCTH $2.60
- 52 Week High
- CLPT $14.13
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- CLPT 50.85
- DCTH 47.05
- Support Level
- CLPT $10.60
- DCTH $9.50
- Resistance Level
- CLPT $12.82
- DCTH $10.04
- Average True Range (ATR)
- CLPT 0.83
- DCTH 0.66
- MACD
- CLPT -0.08
- DCTH -0.10
- Stochastic Oscillator
- CLPT 45.42
- DCTH 22.19
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.